Personalised cancer vaccine expected to be approved next year
A bespoke vaccine that is tailored to target an individual's unique skin cancer reduced rates of recurrence or death in a late-stage trial, making an approval expected
This is a summary aggregated from New Scientist. Read the complete article on the original site:
Read full article at New Scientist
